About Cyclotek
About Us
Making Radiopharmaceuticals Accessible Through Science, Reliability and Partnership
Since 2001, Cyclotek has been at the forefront of improving access to PET radiopharmaceuticals for healthcare providers, researchers, and patients across Australia and New Zealand. Our integrated network brings together specialist manufacturing, time-critical distribution, scientific expertise, and trusted clinical partnerships to deliver reliable access to high-quality radiopharmaceuticals, supporting better diagnostic imaging and improved patient care.
Our Purpose
To make radiopharmaceuticals and radioactive medical devices accessible by delivering reliable supply, supporting clinical and research partners, and helping translate scientific innovation into patient care.
Our Future
To expand access to molecular imaging and next-generation radiopharmaceuticals across Australia, New Zealand and the wider ASEAN region, while continuing to strengthen quality, reliability, research translation and patient impact.
Who we are
A Trusted Partner in Radiopharmaceutical Manufacturing, Supply and Translation
Patients & Families
Supporting access to PET radiopharmaceuticals that can assist earlier, more accurate diagnosis and inform better care pathways.
Hospitals & Clinicians
Reliable supply, responsive support and time-critical coordination for clinical teams delivering PET imaging and therapy services.
Research & University
A translational partner helping move promising radiopharmaceutical science from the laboratory into clinical and commercial pathways.
Pharmaceutical & Industry Partners
GMP manufacturing, technology transfer and clinical trial supply support for organisations developing the next generation of radiopharmaceuticals and radiactive medical devices.
Our Journey
Advancing Molecular Imaging Since 2001
Cyclotek’s story is one of specialist growth: from a single commercial medical cyclotron facility in Victoria to a clinically integrated radiopharmaceutical network supporting healthcare delivery, research and product development across Australia and New Zealand.